In the US, Disopyramide (disopyramide systemic) is a member of the drug class group I antiarrhythmics and is used to treat Arrhythmia.
US matches:
- Disopyramide
- Disopyramide Sustained-Release Capsules
- Disopyramide Phosphate
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C01BA03
CAS registry number (Chemical Abstracts Service)
0003737-09-5
Chemical Formula
C21-H29-N3-O
Molecular Weight
339
Therapeutic Category
Antiarrhythmic agent
Chemical Name
2-Pyridineacetamide, α-[2-[bis(1-methylethyl)amino]ethyl]-α-phenyl-
Foreign Names
- Disopyramidum (Latin)
- Disopyramid (German)
- Disopyramide (French)
- Disopiramida (Spanish)
Generic Names
- Disopiramide (OS: DCIT)
- Disopyramide (OS: USAN, JAN, DCF, BAN)
- H 3292 (IS)
- SC 7031 (IS)
- Searle 7031 (IS: Searle)
- Disopyramid (PH: Ph. Eur. 6)
- Disopyramide (PH: BP 2010, JP XV, Ph. Eur. 6)
- Disopyramidum (PH: Ph. Eur. 6)
- Disopyramide Phosphate (OS: BANM, JAN, USAN)
- SC 13957 (IS: Searle)
- Disopyramide (phosphate de) (PH: Ph. Eur. 6)
- Disopyramide Phosphate (PH: BP 2010, USP 32, Ph. Eur. 6)
- Disopyramidi phosphas (PH: Ph. Eur. 6)
- Disopyramidphosphat (PH: Ph. Eur. 6)
Brand Names
- Chiyoban
Tatsumi Kagaku, Japan - Dicorynan
IFET, Greece; Sanofi-Aventis S.A., Spain - Dimodan
Sanofi-Aventis, Mexico - Disopyramide Jadran
Jadran, Croatia (Hrvatska) - Disopyramide
Remedica, Cyprus; Yung Sine, Taiwan - Disopyran
Tsuruhara Seiyaku, Japan - Disopyra-R
Daito, Japan - Durbis
Aventis, Iceland; Sanofi-Aventis, Sweden - Fanmil
Towa Yakuhin, Japan - Fanmil R
Towa Yakuhin, Japan - Isorythm
Merck Serono, France - Lispine
Sawai Seiyaku, Japan - Lispine R
Sawai Seiyaku, Japan - Mycorten R
Zensei Yakuhin, Japan - Norpace
Pfizer, Japan - Norpace CR
Pfizer, Japan - Palpitin-PP
Pannonpharma, Hungary - Rislamid R
Taisho Yakuhin, Japan - Ritmodan
Sanofi-Aventis, Italy - Rizoramid
Oh Sea HS Shinyaku, Japan - Rizoramid R
Oh Sea HS Shinyaku, Japan - Rythmodan
Aventis, Luxembourg; Aventis, New Zealand; Aventis, Tunisia; Sanofi Aventis, Japan; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Canada; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, South Africa - Rythmodan P
Sanofi Aventis, Japan - Rythmodan R
Sanofi Aventis, Japan - Sopyrat
Nipro PharmaNipurofama, Japan - Disomet
Orion, Finland - Disopyramide PCH
Pharmachemie, Netherlands - Disopyramide Phosphate
Ethex, United States; Generics, Malta; Sandoz, United States; Teva USA, United States; Watson, United States - Disopyramide
KV Pharmaceutical, United States - Durbis
Sanofi-Aventis, Norway - Durbis Retard
Sanofi-Aventis, Sweden - Isorythm LP
Merck Serono, France - Norbit
Incepta, Bangladesh - Norpace
Pfizer, United States; RPG, India - Ritmodan Retard
Sanofi-Aventis, Italy - Ritmodan
Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal - Ritmoforine
Sanofi-Aventis, Netherlands - Rythmical
Unipharm, Israel - Rythmodan
Sanofi-Aventis, Belgium; Sanofi-Aventis, Canada; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Greece; Sanofi-Aventis, Ireland
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment